The Dangers of Marketing Addictive Drugs
New findings about the pressure to sell OxyContin reveal a lot about the opioid crisis.
Stock photo of pills by Flickr user Brandon Giesbrecht
The pharmaceutical company Purdue Pharma began selling OxyContin in 1996. By 2001, it was already clear that addiction and overdoses related to the painkiller were on the rise. Despite the data, however, the company—and its CEO, Richard Sackler—continued to aggressively push the drug. Now, a barrage of lawsuits have been filed against the company for its role in the opioid crisis.
As reporter and author Maia Szalavitz explained in a recent piece for TONIC, newly released documents shine a light on Purdue's history of recklessly marketing OxyContin—and the effects of that marketing are real and dangerous. On this episode of The VICE Guide To Right Now Podcast, we sat down with Szalavitz to learn more.
You can catch The VICE Guide to Right Now Podcast on Acast, Google Play, Apple Podcasts, Stitcher, or wherever you get your podcasts. And sign up for our newsletter to get the best of VICE delivered to your inbox daily.